Won Yoodong, Lee Su Lim, Ku Young Mi, Kim Ki Tae, Won Hye Sung, An Chang Hyeok
Department of Radiology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea,Seoul, Republic of Korea.
Diagn Interv Radiol. 2015 Mar-Apr;21(2):167-72. doi: 10.5152/dir.2014.14260.
We aimed to evaluate the clinical effectiveness and safety of double coaxial self-expandable metallic stent (DCSEMS) in management of malignant colonic obstruction as a bridge to surgery or palliation for inoperable patients.
Between April 2006 and December 2012, 49 patients (27 males and 22 females; median age, 68 years; age range, 38-91 years) were selected to receive decompressive therapy for malignant colonic obstruction by implanting a DCSEMS. Application of DCSEMS was attempted in 49 patients under fluoroscopic guidance. The obstruction was located in the transverse colon (n=2), descending colon (n=7), sigmoid colon (n=24), rectosigmoid junction (n=6), and the rectum (n=10). The intended use of DCSEMS was as a bridge to elective surgery in 23 patients and palliation in 26 patients.
Clinical success, defined as >50% dilatation of the stent with subsequent symptomatic improvement, was achieved in 48 of 49 patients (98%). The stent was properly inserted in all patients. No immediate major procedure-related complications occurred. One patient in the bridge-to-surgery group had colon perforation three days after DCSEMS application. Four patients had late migrations of the double stent.
Application of DCSEMS is safe and effective in management of malignant colonic obstruction; it prevents stent migration and tumor ingrowth and lowers perforation rate during the stent application.
我们旨在评估双同轴自膨式金属支架(DCSEMS)在治疗恶性结肠梗阻方面作为手术桥梁或为无法手术患者提供姑息治疗的临床有效性和安全性。
在2006年4月至2012年12月期间,选择49例患者(男性27例,女性22例;中位年龄68岁;年龄范围38 - 91岁)接受DCSEMS植入以治疗恶性结肠梗阻的减压治疗。在49例患者中尝试在透视引导下应用DCSEMS。梗阻位于横结肠(n = 2)、降结肠(n = 7)、乙状结肠(n = 24)、直肠乙状结肠交界处(n = 6)和直肠(n = 10)。DCSEMS的预期用途是作为23例患者择期手术的桥梁和26例患者的姑息治疗。
49例患者中有48例(98%)取得了临床成功,定义为支架扩张>50%且随后症状改善。所有患者的支架均正确植入。未发生立即的重大手术相关并发症。手术桥梁组中有1例患者在DCSEMS应用后三天出现结肠穿孔。4例患者出现双支架的晚期移位。
DCSEMS在治疗恶性结肠梗阻方面安全有效;它可防止支架移位和肿瘤长入,并降低支架应用期间的穿孔率。